Cardiology Services - Cardiac-Pulmonary
Rehabilitation
PCRMC offers both Phase II and Phase III
Rehabilitation Programs for
Cardiac and Pulmonary Patients
Click the links below for additional information
Cardiac Rehabilitation
Pulmonary Rehabilitation
Cardiac Rehabilitation - Back to the top
Phase II Cardiac Rehabilitation
Phase II refers to an outpatient, medically supervised program that is typically
initiated 1 to 3 weeks after hospital discharge and provides appropriate
electrocardiography monitoring. It is a comprehensive program that includes
the following components:
A medical evaluation;
A program to modify cardiac risk factors such as nutritional counseling
Prescribed exercise, Education, Counseling
2 to 3 sessions per week for 12 to 18 weeks not to exceed 72 sessions within
a 36 week period
Phase II Criteria
Have a documented diagnosis of acute MI within the preceding 12 months
Have had coronary bypass surgery
Have stable angina pectoris
Have had heart valve repair/replacement
Have had percutaneous transluminal coronary angioplasty (PTCA) or coronary
stenting
Have had a heart or heart/lung transplant
Phase III Criteria (Phase III Criteria is very similar to Phase II with the
following exceptions :)
Completion of Phase II Program is required
Patients are monitored for weight and blood pressure however; patients are
not
Electrocardiography monitored.
Pulmonary Rehabilitation - Back to
the top
Phase II Pulmonary Rehabilitation
A medical evaluation
A program to modify pulmonary risk factors
Such as nutritional counseling, smoking cessation
Prescribed exercise
Education
Counseling
2 sessions per week for 15 weeks; not to exceed 30 sessions within a 52 week
period
Phase II Criteria
FEV 1.0 less than or equal to 65% predicted value
FVS less than or equal to 65% predicted value
Diffusing capacity for carbon monoxide adjusted for
Hemoglobin less than or equal to 65% predicted value
Resting hypoxemia (Spo2 less than or equal to 90%)
Exercise testing demonstrating hypoxemia (Spo2 less than or equal to 90%)
or ventilatory limit (VE/MVV than or equal to 0.8) or a rising Vd/Vt
| Obstructive Diseases: |
Interstitial disease |
COPD (including alpha-1 antitrypsin deficiency)
Persistent asthma
Bronchiectasis
Cystic fibrosis
Bronshiolitis obliterans
|
Interstitial fibrosis
Occupational or environmental lung disease
Sarcoidosis
|
| Chest Wall diseases |
Neuromuscular diseases: |
Kyphoscoliosis
Ankylosing spondylitis
|
Parkinson’s disease
Post-polio syndrome
Amyotrophic lateral sclerosis
Diaphragmatic dysfunction
Multiple sclerosis
Post-tuberculosis syndrome
|
| Other Conditions |
Phase III Criteria |
Lung Cancer
Pre and post thoracic and abdominal surgery
Pre and post lung volume reduction surgery
Ventilatory dependency
Pediatric patients with respiratory disease
Obesity related respiratory disease
|
(Phase III Criteria is very similar to Phase II with the following exceptions:)
Completion of Phase II Program is required
Patients are monitored for weight and blood pressure however; they are
not electrocardiography monitored as they exercise
|
Home | Services | Cardiology Services Home
|